• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of Nephrogenic Systemic Fibrosis in Stage 4 and 5 Chronic Kidney Disease Following Group II Gadolinium-based Contrast Agent Administration: Subanalysis by Chronic Kidney Disease Stage.

作者信息

Shankar Prasad R, Davenport Matthew S

机构信息

From the Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UHB2A209P, Ann Arbor, MI 48109 (P.R.S., M.S.D.); Michigan Radiology Quality Collaborative, University of Michigan, Ann Arbor, Mich (P.R.S., M.S.D.); and Department of Urology, Michigan Medicine, Ann Arbor, Mich (M.S.D.).

出版信息

Radiology. 2020 Nov;297(2):447-448. doi: 10.1148/radiol.2020201492. Epub 2020 Aug 18.

DOI:10.1148/radiol.2020201492
PMID:32808890
Abstract
摘要

相似文献

1
Risk of Nephrogenic Systemic Fibrosis in Stage 4 and 5 Chronic Kidney Disease Following Group II Gadolinium-based Contrast Agent Administration: Subanalysis by Chronic Kidney Disease Stage.给予II类钆基造影剂后4期和5期慢性肾脏病患者发生肾源性系统性纤维化的风险：按慢性肾脏病分期进行的亚分析
Radiology. 2020 Nov;297(2):447-448. doi: 10.1148/radiol.2020201492. Epub 2020 Aug 18.
2
Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.肾源性系统性纤维化：一种由钆暴露引起的全身性纤维性疾病。
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):489-503. doi: 10.1016/j.berh.2012.07.008.
3
Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.肾源性系统性纤维化：一种与钆相关的肾功能不全患者的纤维化疾病。
Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii66-9. doi: 10.1136/ard.2008.102475.
4
Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media.肾功能、肾源性系统性纤维化及与钆基造影剂相关的其他不良反应。
Nefrologia. 2014;34(4):428-38. doi: 10.3265/Nefrologia.pre2014.Apr.12375.
5
Current status of nephrogenic systemic fibrosis.肾源性系统性纤维化的现状。
Clin Radiol. 2014 Jul;69(7):661-8. doi: 10.1016/j.crad.2014.01.003. Epub 2014 Feb 28.
6
Gadolinium and nephrogenic systemic fibrosis: have we overreacted?钆与肾源性系统性纤维化：我们反应过度了吗？
Semin Dial. 2011 Sep-Oct;24(5):480-6. doi: 10.1111/j.1525-139X.2011.00945.x. Epub 2011 Sep 13.
7
Ocular pathologic features and gadolinium deposition in nephrogenic systemic fibrosis.
Arch Ophthalmol. 2011 May;129(5):661-3. doi: 10.1001/archophthalmol.2011.89.
8
Safety of magnetic resonance contrast media: a review with special focus on nephrogenic systemic fibrosis.磁共振造影剂的安全性：特别关注肾源性系统性纤维化的综述
Top Magn Reson Imaging. 2015 Feb;24(1):57-65. doi: 10.1097/RMR.0b013e3182a14e79.
9
Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.预防钆诱导的肾源性系统性纤维化的预防性血液透析：一个玩偶之家。
Adv Chronic Kidney Dis. 2017 May;24(3):133-135. doi: 10.1053/j.ackd.2017.03.007.
10
[Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction--second edition].[肾功能不全患者使用钆对比剂的指南——第二版]
Nihon Jinzo Gakkai Shi. 2009;51(7):839-42.

引用本文的文献

1
Update in Imaging Evaluation of Bone and Soft Tissue Sarcomas.骨与软组织肉瘤的影像学评估进展
Rev Bras Ortop (Sao Paulo). 2021 Nov 11;58(2):179-190. doi: 10.1055/s-0041-1736569. eCollection 2023 Apr.
2
Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials.改善慢性肾脏病患者的癌症护理：临床试验变革的必要性。
Kidney Int Rep. 2022 Jun 15;7(9):1939-1950. doi: 10.1016/j.ekir.2022.06.005. eCollection 2022 Sep.
3
Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.
基于钆的静脉造影剂在肾病患者中的应用：美国放射学会和美国国家肾脏基金会的共识声明
Kidney Med. 2020 Nov 10;3(1):142-150. doi: 10.1016/j.xkme.2020.10.001. eCollection 2021 Jan-Feb.